GlassScriptPhysician profile
Blythe E Monheit
NPI 1336196542
$3,434.92
in general payments reported to CMS, 2019-2025
14 companies · $509 in 2025
The $509 reported for 2025 was less than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $330 · 2021: $653 · 2022: $612 · 2023: $390 · 2024: $606 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,504.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,086.21 | 2020-2025 | Clareon, Rocklatan, Centurion |
| Allergan, INC. | $729.43 | 2019-2022 | |
| Abbvie INC. | $408.57 | 2022-2024 | |
| New World Medical,INC. | $297.01 | 2024-2025 | Streamline, Ahmed Glaucoma Valve, Clearpath |
| Heidelberg Engineering, INC. | $184.27 | 2021 | |
| Sight Sciences, INC. | $147.08 | 2024 | Omni Surgical System |
| Horizon Therapeutics Plc | $124.40 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $121.95 | 2021 | |
| Aerie Pharmaceuticals, INC. | $117.87 | 2019 | |
| Biotissue Holdings INC. | $105.93 | 2019 | |
| Thea Pharma INC. | $57.01 | 2025 | Iyuzeh |
| Bausch & Lomb Americas INC. | $31.70 | 2025 | Vyzulta |
| Dompe US, INC. | $23.49 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blythe Monheit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.